If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY.
Description
Anti-PDCD1 Therapeutic Antibody (OPDIVO). Recombinant human monoclonal antibody expressed in CHO binding to human PDCD1. Nivolumab is a fully human IgG4 monoclonal antibody for the treatment of cancer. Nivolumab acts as an immunomodulator by blocking ligand activation of the programmed cell deathSuitable for use in FuncS, IF, Neut, ELISA, FC, IP, ICC and most other immunological methods.
Immunogen
n/a
Other Names
nivolumab;opdivo;946414-94-4;ONO-4538;MDX-1106;BMS-936558;5C4;Opdivo;ONO-4538;BMS-936558;MDX1106;PDCD1;programmed cell death 1;programmed cell death protein 1;CD279;PD1;protein PD-1;PD-1;SLEB2;hPD-1;hPD-l;